Middle cerebral artery mean velocity (MCAvmean) is attenuated with increasing age both at rest and during exercise. The aim of this study was to determine the influence of the age-dependent reduction in arterial PCO2 (PaCO2) and physical fitness herein. We administered supplemental CO2 (CO2 trial) or no additional gas (control trial) to the inspired air in a blinded and randomized manner, and assessed middle cerebral artery mean flow velocity during graded exercise in 1) 21 young [Y; age 24 Ϯ 3 yr (ϮSD)] volunteers of whom 11 were trained (YT) and 10 considered untrained (YUT), and 2) 17 old (O; 66 Ϯ 4 yr) volunteers of whom 8 and 9 were considered trained (OT) and untrained (OUT), respectively. A resting hypercapnic reactivity test was also performed. MCAvmean and PaCO2 were lower in O [44.9 Ϯ 3.1 cm/s and 30 Ϯ 1 mmHg (ϮSE)] compared with Y (59.3 Ϯ 2.3 cm/s and 34 Ϯ 1 mmHg, P Ͻ 0.01) at rest, independent of aerobic fitness level. The age-related decreases in MCAvmean and PaCO2 persisted during exercise. Supplemental CO2 reduced the age-associated decline in MCAv mean by 50%, suggesting that PaCO2 is a major component in the decline. On the other hand, relative hypercapnic reactivity was neither influenced by age (P ϭ 0.46) nor aerobic fitness (P ϭ 0.36). Although supplemental CO2 attenuated exercise-induced reduction in cerebral oxygenation (near-infrared spectroscopy), this did not influence exercise performance. In conclusion, PaCO2 contributes to the age-associated decline in MCAvmean at rest and during exercise; however exercise capacity did not diminish this age effect. brain blood flow; middle cerebral artery; old; transcranial Doppler CEREBRAL BLOOD FLOW (CBF) is meticulously regulated to ensure an adequate perfusion of the brain. With exercise middle cerebral artery mean velocity (MCAv mean ; a surrogate measure of CBF) is increased until ϳ60% of maximal oxygen uptake (V O 2max ) but thereafter declines toward resting levels (10, 20, 28) . In young healthy individuals this drop in cerebral perfusion is likely the consequence of a hyperventilation facilitated reduction in PaCO 2 and hence augmented cerebral vasoconstriction (39). Accordingly, administration of CO 2 to the inspired air during exercise abolishes the decrease in MCAv mean (44, 45) , and during vigorous exercise MCAv mean is regulated by PaCO 2 and only to a lesser extent influenced by cerebral metabolism, mean arterial pressure (MAP), cardiac output, or sympathetic nerve activity (35).
sion is likely the consequence of a hyperventilation facilitated reduction in PaCO 2 and hence augmented cerebral vasoconstriction (39) . Accordingly, administration of CO 2 to the inspired air during exercise abolishes the decrease in MCAv mean (44, 45) , and during vigorous exercise MCAv mean is regulated by PaCO 2 and only to a lesser extent influenced by cerebral metabolism, mean arterial pressure (MAP), cardiac output, or sympathetic nerve activity (35) .
Compared with young healthy individuals a reduced CBF (24) and MCAv mean has consistently been reported in the aged population both at rest (2, 7, 9, 15, 25, 27, 49) and during exercise (9, 10, 28, 32) . Although a reduced MCAv mean response in aged humans is observed with exercise, its pattern follows that of young individuals, i.e., an initial increase which is then followed by a decline as the exercise intensity becomes intense (9, 10, 28, 32) . The regulating mechanisms for the reduction in CBF with age remain uncertain and global brain atrophy (11) , decreased neuronal activity (29) , increased arterial stiffness (12, 50) , and reduced cerebrovascular reactivity (12, 22) have all been proposed as important factors. In addition, the concomitantly occurring and age-dependent decrease in PaCO 2 at rest (9) and during exercise (9, 28) may be involved in the age-associated reduction in cerebral perfusion. This however has not been tested experimentally, and is one aim of the present study. An age-related reduction in CO 2 reactivity could also diminish the CBF response to exercise. The effect of aging on CO 2 reactivity is not clear, however, as hypercapnic reactivity has been demonstrated to be either unchanged (15, 24, 42) , reduced (4, 22, 48) , or even elevated (49) with increasing age. One reason for the discrepancies could be related to the use of humans over a narrow age range, and with varying degrees of physical fitness. Thus a further aim related to this study was to quantify CO 2 reactivity and to investigate its association to the decrease in MCAv mean with age.
A high aerobic fitness level appears to attenuate the agerelated decline in resting CBF (39) and MCAv mean (1) (2) (3) 46) , although this has not been universally observed (4, 49) . Whether fitness is a factor affecting CBF during exercise remains unclear. Moreover, aerobic fitness may affect hypercapnic cerebrovascular reactivity (4, 32, 49) , although these findings are also contradictory as increased (3, 32) , unchanged (49) and decreased (46) hypercapnic reactivity has been reported in aerobically trained individuals. Again potential influencing factors for the widespread results could include differences in age and fitness levels across studies.
Accordingly the purpose of the present study was fourfold: 1) to determine the effect of age on hypercapnic reactivity compared with healthy young individuals, 2) to establish the importance of the age-related drop in PaCO 2 on MCAv mean by administering supplemental CO 2 to the inspiration during exercise, 3) to examine the effects of physical fitness on hypercapnic reactivity and the age-related decrease in MCAv mean by comparing aged and young individuals that are aerobically trained or untrained, and 4) to investigate whether maintaining MCAv mean and thereby cerebral oxygenation would lead to an improvement in exercise capacity in young and older individuals. We hypothesized that supplementing the inspired air with CO 2 during exercise would reduce the age-related reduction in MCAv mean . Second, we hypothesized that elderly individuals with superior aerobic fitness would possess a higher MCAv mean than their untrained peers both at rest and during exercise, and that this difference would also be accompanied by a higher hypercapnic reactivity. Finally we expected that improvements in MCAv mean elicited by CO 2 supplementation would not lead to an improved exercise capacity.
METHODS
All experimental protocols and procedures conformed to the Declaration of Helsinki and were approved by the ethical committee of the Swiss Federal Institute of Technology Zürich (EK 2013-N-17). Prior to participation, a detailed verbal and written explanation of the study was provided, and written informed consent to take part in this study was obtained from each participant. Subjects were screened by means of a general health questionnaire to identify any history or symptoms of cardiovascular (e.g., hypertension), pulmonary, metabolic, or neurological disease or use of medications. We recruited 21 young (Y TϩUT) males and 24 older (OTϩUT) males to participate in the study. Based on an evaluation of their medical history and a physical examination, as well as a 12-lead resting ECG assessing abnormality of the heart, seven older subjects were excluded from participating in the study. Consequently, 21 YTϩUT [24 Ϯ 3 yr (ϮSD)] and 17 OTϩUT (66 Ϯ 4 yr) completed the study. Subject groups were also divided into trained (T) and untrained (UT) groups independent of the type of training performed, first by self-assessment and then confirmed by their achievement in the maximal incremental exercise test (43) during their preliminary visit to the laboratory. Consequently 11 young trained (V O2max: 65.6 Ϯ 1.0 ml·kg Ϫ1 ·min Ϫ1 ; YT), 10 young untrained (49.6 Ϯ 1.8 ml·kg Ϫ1 ·min Ϫ1 ; YUT), 8 older trained (40.5 Ϯ 2.5 ml·kg Ϫ1 ·min Ϫ1 ; OT), and 9 older untrained (29.6 Ϯ 1.3 ml·kg Ϫ1 ·min Ϫ1 ; OUT) individuals participated in the study (Table 1) . During a preliminary visit to the laboratory, subjects were familiarized with the exercise tests and the study set-up. On the second visit to the laboratory a hypercapnic reactivity test plus two maximal incremental exercise tests were performed, one without and one with additional CO2 to inspiration. Between subjects the tests were conducted at different times of the day; however, within-subject comparison data were assessed at the same time of the day. Subjects were requested to abstain from strenuous physical activity for 24 h, and alcohol and caffeine for 12 h prior to experimental sessions. Monitoring procedures associated with medical safety during exercise were performed in real-time by a physician and included a 12-lead ECG, oscillometric noninvasive blood pressure measurements with a 3 min monitoring interval and a ST elevation check of I-aVF, V1-V6, in a 1-min interval. Termination criteria for the exercise test were systolic blood pressure above 220 mmHg or a 10-mmHg drop below baseline, ST anomalies, arrhythmias, and symptoms such as dizziness, syncope, or cyanosis. Posttest monitoring was for 15 min if asymptomatic and if BP and ECG reached baseline values. No test participants were excluded on the basis the above investigations.
Experimental measures. MCAvmean was assessed using transcranial Doppler ultrasonography (Doppler Box, DWL, Sipplingen, Germany) with a 2 MHz probe placed over the right temporal window, prepared with ultrasound gel. The probe was held in place with a snug-fitting headgear. Mean arterial pressure (MAP) was recorded continuously and noninvasively via finger photoplethysmography (Nexfin, BMEYE B.V, Amsterdam, Netherlands) and heart rate (HR) was assessed by a monitor belt (Cosmed Quark b2, Rome, Italy). MCAv mean and MAP were sampled at 1,000 Hz and stored for offline analysis (LabChart 7 Pro v7.3.5 and Powerlab, ADInstruments, Bella Vista, NSW, Australia). By wearing a mask covering nose and mouth (Hans Rudolph) respiratory variables were measured breath-by-breath using a spirometer. A capillary blood sample was obtained from the right ear lobe at BL, and during exercise at 100 W, at 75% maximal workload (Wmax), and at exhaustion. Capillary PCO 2 (PcapCO2), pH, and HCO3 Ϫ were measured using a blood gas analyzer (ABL800, Radiometer, Copenhagen, Denmark). Cerebral and muscle tissue oxygenation (cerebral and muscle StO 2) were continuously assessed on the left forehead and right vastus lateralis muscle, respectively, by nearinfrared spectroscopy (NIRS; Invos-5100c, Covidien, Mansfield, MA).
Hypercapnic reactivity test. Hypercapnic reactivity test was performed by adding CO 2 to the inspired air (Altitrainer, SMTEC, Nyon, Switzerland) with subjects in a semisupine position. After a 10-min resting phase, PaCO2 (estimated from end-tidal PCO2) was recorded for 3 min following which the CO2 reactivity test protocol was undertaken. The protocol consisted of three steps of 120 s: step 1 (PaCO2 ϭ ϩ1.5 mmHg above resting values), step 2 (PaCO2 ϭ ϩ6.5 mmHg above resting values), and recovery (PaCO2 ϭ ϩ1.5 mmHg above resting values). Maintaining PaCO2 at 1.5 mmHg above resting values facilitates PaCO2 control (21) and reduces breath-to-breath variability in cerebral blood flow velocity (19) .
Exercise test. During the preliminary visit to the laboratory each subject performed a maximal incremental exercise test on a cycle ergometer (Monark E 839, Varberg, Sweden) to determine their Wmax and V O2max using a protocol starting with a warm-up period of 5 min at 100 W (YT), 150 W (YT), 20 W (OUT), or 50 W (OT). Thereafter the workload was increased every minute by 30 W (YT, YUT and OT) or 20 W (OUT) until exhaustion.
On the second visit to the laboratory subjects completed two incremental exercise tests in a blinded and randomized manner without (control trial) and with supplemental inspired CO 2 (CO2 trial). The trials were separated by at least 90 min to limit any potential carryover effect (41) . The workload selected during the exercise protocol was based on the Wmax achieved during the maximal incremental exercise test performed on the first visit. Both the control trial and the CO 2 trial followed the same individualized protocol consisting of two absolute workloads (60 W, 100 W) and four relative workloads (25% Wmax, 50% Wmax, 75% Wmax, and 100% Wmax). The first four workloads were set to last 3 min each, the fifth workload for 2 min, and the final workload (100% Wmax) was performed until exhaustion. The duration that the subjects were able to sustain 100% Wmax was used as a measure of exercise performance. This protocol design allows comparison between groups at the same absolute and relative exercise intensities. Prior to each exercise test a 2 min resting measurement on the cycle ergometer (BL) was conducted. The control trial was performed without the addition of supplemental inspired CO 2 whereas PaCO2 was continuously monitored in the CO2 trial and when PaCO2 dropped below 40 mmHg CO2 was added to the inspired air preventing the exercise-induced drop in PaCO2.
Data analysis and calculations. Data were recorded continuously. Resting PaCO2 and PaCO2 during the hypercapnic reactivity test was estimated from end-tidal PCO2 (PETCO2) by the equation (37) Resting MCAv mean, MAP, and PaCO2 were averaged over the last minute of the resting phase prior to the hypercapnic reactivity test. Baseline, absolute, and relative exercise intensity values represent an average over 1 min whereas the "last 20 s" time point represents an average of the last 20 s of each exercise trial. This was chosen to reduce the chance of missing the changes in the measured parameters at maximal exercise shortly before exhaustion. Cerebrovascular conductance (CVC) was calculated as MCAv mean divided by MAP. CO2 reactivity was calculated as absolute and relative changes in MCAv mean divided by the increase in PaCO2. Additionally CVC CO2 reactivity was calculated as CVC changes divided by the increase in PaCO2.
Statistics. Comparisons of resting values were made using a twoway ANOVA with the main factors being age (young vs. old) and training status (trained vs. untrained). For each the absolute and relative exercise intensities a separate four-way ANOVA was used for exercise variable comparisons, where the main factors were age, training status, intensity (BL, 60 W, 100 W and BL, 25%, 50%, 75%, 100% Wmax, last 20 s) and condition (control vs. CO 2 trial). Tukey's range test was applied for post hoc analysis. Statistical significance was set at P Ͻ 0.05. Statistical analyses were performed using SAS Enterprise Guide (4.3, SAS Institute, Cary, NC).
RESULTS
All 38 volunteers completed the study. Independent of the participant's physical fitness level there was a main age effect between the Y TϩUT and the O TϩUT ( Table 1 . V O 2 , carbon dioxide production (V CO 2 ), and respiratory exchange ratio (RER) are presented in Table 2 .
Hypercapnic reactivity test. PaCO 2 was increased (P Ͻ 0.01) from step 1 to step 2 in Y TϩUT (38.1 Ϯ 0.5 to 42.2.0 Ϯ 0.6 mmHg) and O TϩUT (34.5 Ϯ 0.7 to 38.5 Ϯ 0.7 mmHg). Concomitantly MAP was augmented by 3.3 Ϯ 0.8 and 5.3 Ϯ 0.8 mmHg in Y TϩUT and O TϩUT , respectively. Hypercapnic reactivity data (Table 1) are presented in absolute and relative MCAv mean as well as absolute CVC changes to 1 mmHg increase in PaCO 2 . Neither of these differed between the age groups and trained vs. untrained study volunteers. CVC CO 2 reactivity, however, tended (P ϭ 0.06) to be slightly lower with age. MAP responses to exercise are presented in Fig. 1C . Training status did not show an effect on MAP response during absolute or relative exercise intensities in both age groups (P Ͼ 0.58). CVC for the control and CO 2 trial and both age groups is presented in Fig. 1D . At absolute and relative exercise intensities a main effect of age was apparent. In agreement with MCAv mean , CVC was also increased at 100% Wmax and the last 20 s in the CO 2 trial compared with the control trial in both age groups.
Ventilation and exercise performance in the control vs. the CO 2 exercise trial. Ventilation (V E) was elevated with increasing exercise intensity (P Ͻ 0.01); however, it was not different between Y TϩUT and O TϩUT at BL, 60 W, and 100 W (14.7 Ϯ 0.6 vs. 14.6 Ϯ 0.7, 34.7 Ϯ 0.8 vs. 34.7 Ϯ 1.5 and 47.1 Ϯ 1.3 vs. 51.4 Ϯ 2.0 l/min, P ϭ 0.22). Analysis of V E during relative exercise intensities revealed an interaction between age and intensity (P Ͻ 0.01), and at 75% Wmax (96.8 Ϯ 3.1 vs. 73.8 Ϯ 2.6 l/min), 100% Wmax (134.5 Ϯ 3.4 vs. 87.8 Ϯ 2.8 l/min), and last 20 s (140.0 Ϯ 3.6 vs. 90.6 Ϯ 3.1 l/min) V E was elevated in Y TϩUT vs. O TϩUT . A main effect of condition was only apparent when absolute intensities [e.g., 100 W in O TϩUT : 48.9 Ϯ 2.4 vs. 53.9 Ϯ 3.2 l/min, control vs. CO 2 trial (P Ͻ 0.01)] were evaluated, whereas there was no main effect of condition when relative exercise intensities were assessed (P ϭ 0.52).
The duration at 100% Wmax was lower in the O TϩUT compared with the Y TϩUT (P Ͻ 0.01), independent of their fitness level (P ϭ 0.49). Additionally both age groups sus- Trained vs. untrained study volunteers. Figure 2 illustrates the same data as in Fig. 1 (Fig. 1) except that the magnitude of the age-related difference in the MCAv mean and PaCO 2 response to exercise was diminished. The supplemental CO 2 given to inspiration resulted in a greater increase in CO 2 in the O TϩUT compared with the Y TϩUT during exercise at the same absolute intensity.
Capillary blood samples. Due to an insufficient volume of blood being obtained from some of the participants these data are derived from n ϭ 13 ( age (P Ͻ 0.01) was observed in pH, but there was no main effect of either condition (P ϭ 0.14) or training status (P ϭ 0.44). No main effects of condition (P ϭ 0.99) or training (P ϭ 0.23) were found for HCO 3 Ϫ , but there was an interaction between age and intensity (P Ͻ 0.01). At exhaustion HCO 3 Cerebral and vastus lateralis muscle oxygenation. Cerebral StO 2 was increased in response to supplemental CO 2 whereas muscle StO 2 was unaffected (Fig. 3) . Changes in cerebral and muscle oxygenation followed a similar pattern in both age groups; however, greater decreases in muscle oxygenation were observed in the young group when relative exercise intensities were compared.
DISCUSSION
In support of the study aims the major findings include: 1) confirmation of the age-associated decrease in PaCO 2 and MCAv mean at rest and during exercise; 2) hypercapnic cerebrovascular reactivity is not altered with increased age; 3) the experimentally induced increase in PaCO 2 abolished Ϸ50% of the age-related reduction in MCAv mean during exercise; 4) aerobic fitness in young and older humans does not influence MCAv mean at rest or during exercise; and 5) improvements in cerebral oxygenation by CO 2 administration do not lead to improved exercise performance in either young or older study participants.
Influence of age on resting PaCO 2 and MCAv mean . The reduction in resting MCAv mean with age observed in the present study is in agreement with studies assessing CBF using transcranial Doppler ultrasonography (7, 9, 15, 32, 49) , the Kety-Schmidt technique (25) , and arterial spin labeling MRI (27) . Possible mechanisms for the age-related decrease in CBF include decreased neuronal activity (29) , increased arterial stiffness (50), reduced cerebrovascular reactivity (22) , and global brain atrophy (11) , although the latter has been argued not to contribute to the age-related decline in CBF (6). Reduced PaCO 2 has also been associated to the age-related decrease in MCAv mean (9) and in agreement herewith we observed that PaCO 2 and MCAv mean are both lower in the older study participants. Others, however, have not demonstrated such a relationship (15, 28, 32, 49) , although three of four of these studies reported that PaCO 2 was 1 to 2.8 mmHg lower in the older subjects. A possible explanation for PaCO 2 to be lower with age in some humans could be secondary to age-related metabolic acidosis (13) . However, in a follow up study the same authors reported elevated blood acidity in the elderly, but no age-related difference in PaCO 2 was reported (14) . Furthermore, in the present study resting capillary blood pH was not reduced with age, and does hence not support an age-related acidosis, at least in the subjects participating in the present study.
PaCO 2 and MCAv mean during exercise in old and young humans. In the present study PaCO 2 increased gradually in the young and older groups until an exercise intensity of Ϸ75% Wmax was reached, and thereafter declined in agreement with previous work (10, 20) . Although MCAv mean followed a similar pattern, the decline, however, was less apparent. Cerebrovascular conductance (CVC; MCAv mean /MAP) exhibited a diminished elevation with increasing exercise intensity and was markedly decreased at maximal exercise (Fig. 1) . This could be indicative of MAP being the dominating force increasing CBF during the early light phase of exercise (39) and the subsequent switch to PaCO 2 becoming the dominant regulator of CBF at higher exercise intensities.
Age did not influence the response pattern of MCAv mean , PaCO 2 , or CVC; however, in the older group, lower MCAv mean , PaCO 2 , and CVC values were observed throughout compared with the younger participants (Fig. 1) . Possible mechanisms underlying this age effect remain unclear. To test the importance of PaCO 2 for the age-associated decrease in MCAv mean , young and old volunteers performed an exercise trial with CO 2 administered to the inspired air. This approach has been used in different settings (8, 36, 44) and proven effective in maintaining or increasing PaCO 2 and MCAv mean (36, 44) . When increasing PaCO 2 in the aged population to values similar to those observed in the young controls (Fig. 1A) , Ϸ50% of the age-related difference in MCAv mean was abolished (Fig. 1B) , indicating that although a major part of the reduction in MCAv mean with age is related to the lower PaCO 2 , other factors are also involved. It has been suggested that differences in PaCO 2 may account for 30% of the age-related decline in MCAv mean (1) , and thus according to the present study this may be somewhat an underestimate. As MCAv mean and PaCO 2 in young and old participants present an age-related difference already at rest, the difference observed during exercise could derive from here. The percentage change in MCAv mean during exercise was similar in young and old and in agreement with a previous study (28) , although at 50% V O 2peak a lower MCAv mean response was observed in the elderly. Similarly, the percent changes from baseline in PaCO 2 were comparable in young and old participants. Thus exercise does not appear to exacerbate the age-related difference in PaCO 2 and MCAv mean manifested at rest.
As PaCO 2 accounts for Ϸ50% of the age related decrease in MCAv mean , other factors must also contribute to the decline. As mentioned decreased neuronal activity (29) , increased arterial stiffness (50) and reduced cerebrovascular reactivity (4, 22, 48) are potential contributors. Cerebrovascular reactivity, which in the current study was assessed as hypercapnic reactivity, demonstrated no difference between the two groups when expressed as absolute and relative changes in MCAv mean , in support of previous studies (15, 24) . Unfortunately none of these studies determined CVC reactivity. In the present study a trend (P ϭ 0.06) toward a reduced hypercapnic reactivity was evident. In contrast an increase in hypercapnic reactivity, calculated as relative and CVC changes, in elderly has been reported (49) . Since no apparent explanation seems at hand for the discrepancies, the inconsistencies in hypercapnic reactivity results might arise from differences in the CBF measurement techniques, CO 2 stimulus, and age range of the study participants. In future studies blood pressure changes and therefore CVC reactivity should also be taken into consideration.
Despite having a lower MCAv mean this may not necessarily also lead to a lower brain oxygenation in the elderly, as a reduced oxygen delivery to the brain may be compensated for by an augmented oxygen extraction and thereby maintain cerebral oxygenation (34). Fisher et al. (9) however demonstrated similar cerebral oxygenations despite differences in cerebral perfusion between young and older individuals. In the present study brain delta oxygenation also did not differ between age groups; one limitation, however, is that we assessed tissue oxygenation index and not absolute oxy-and deoxyhemoglobin values or direct arterio-venous differences.
The influence of aerobic fitness on MCAv mean and hypercapnic reactivity. Physical activity has been suggested to maintain MCAv mean and cerebrovascular reactivity (2, 32) . In the present study aerobic fitness neither in the young nor in the old group influenced resting MCAv mean or hypercapnic reactivity. Recent studies (4, 49) also reported a lack of an association between fitness and MCAv mean in young vs. older individuals. In contrast, life-long physical activity/training has shown an attenuated age-dependent decline in resting MCAv mean (2, 3) and CBF (2, 3, 46) . When the same relative exercise intensities were compared the trained study participants displayed a higher PaCO 2 in the control trial, and this was independent of age. The reason could be related to the fact that trained participants were exercising at a higher absolute workload and hence also at a higher V O 2 and in most instances therefore also higher PaCO 2 . The elevated PaCO 2 in trained subjects did not lead to a concomitant higher MCAv mean although trained study volunteers, especially the trained older, had a higher MCAv mean during exercise, although not reaching statistical significance (P ϭ 0.16). Several studies have investigated the influence of aerobic fitness on hypercapnic reactivity, and in agreement with our results Zhu et. al (49) demonstrated no effect of aerobic fitness on hypercapnic reactivity. As indicated with respect to the effects of age, the effects of aerobic exercise capacity on hypercapnic reactivity are inconsistent and range from increased (3) to decreased (46) reactivities in trained individuals.
The influence of cerebral oxygenation on exercise limitations. The gradual decline in CBF with exercise intensity above a certain threshold also reduces cerebral oxygenation. This has been speculated to lead to centrally mediated fatigue (17, 33) . A unique feature of CO 2 supplementation is that whereas MCAv mean and cerebral oxygenation are increased, oxygenation of the exercising skeletal muscles remains unaffected by the intervention (Fig. 3) , and hence the isolated influence of altered brain oxygenation can be assessed. In the present study a reduced decline in cerebral oxygenation did not result in a higher exercise capacity. Our results are in line with recent work (44, 45) and hence support that brain oxygenation is not a parameter of importance for fatigue development during maximal exercise. Indeed, supplemental CO 2 administered to the inspired air tended to reduce exercise performance as the duration of the 100% Wmax step was shorter during the CO 2 trial. One potential reason for the negative influence of CO 2 administration to exercise performance is a hyperventilation-induced acidification (45, 47) . Previous studies have not assessed blood gas variables at maximal exercise when CO 2 was administrated. Capillary pH was unaffected by the supplemental CO 2 gas. CO 2 induced hyperventilation could direct blood flow away from the exercising muscles and support the additional work and metabolic demand of the respiratory muscles. However, ventilation did not differ between the control and CO 2 trial.
Limitations. We assessed MCAv mean by TCD as a surrogate for CBF. MCAv mean is a measure of blood flow velocity and not a flow in absolute terms. Nevertheless the two are highly correlated (5) . The majority of studies have illustrated that the diameter of the MCA does not change in response to hypercapnia (16, 38) . Thus assessment of blood velocity using TCD has been accepted as a reliable measure of CBF and is widely used to study age and exercise-related effects (9, 10, 28, 32) . In the present study we focused on PaCO 2 as it is one of the major CBF regulators; however, whether it is PaCO 2 or in fact pH, or both, that are responsible for the hypercapnia-induced vasodilation remains uncertain. Studies manipulating arterial pH, extravascular pH, and PaCO 2 proposed changes in extravascular pH to be responsible for the hypercapnia-induced vasodilation (18, 26) . In the present study baseline pH values did not differ between age groups, suggesting and agreeing with the above that capillary pH may not be the main factor responsible for the decrease in MCAv mean in older individuals. It can, however, not be ruled out that extravascular pH may have been different in the two populations and thereby at least partly involved.
Trained study volunteers were included independent of their regimen of training conducted. This could have become a problem since it is still debated whether resistance training leads to increased arterial stiffness (31) or not (40) . However, since none of the subjects were predominantly engaged in resistance training this is likely not to have influenced the study outcome. Since only male volunteers were examined this also implies that the obtained data may not necessarily be valid for female although differences are not apparent (30) . The PaCO 2 values reported in the present study are derived from PETCO 2 ; however, there are studies reporting good correlations between the two. Also in the present study the actually obtained capillary blood gases correlated well with the PaCO 2 estimated from the obtained PETCO 2 .
Conclusion. In conclusion, reduced CBF was associated with a lower PaCO 2 at rest and during exercise in older men. Supplemental CO 2 diminished the age-related reduction in CBF by Ϸ50% during exercise. An elevated aerobic capacity did not lead to increased cerebrovascular health either in our young or in our older study participants. Finally, despite the maintained oxygenation during the CO 2 trial exercise performance did not improve, indicating decreased cerebral oxygenation not to be a limiting factor.
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